At the ongoing J.P. Morgan Healthcare Conference, Inspire Medical Systems boasted a five-year revenue set to grow at a CAGR ...

In 2025, the U.S. Food and Drug Administration (FDA or the Agency) issued a surprising number of enforcement letters to ...

Inquis Medical, Inc., a privately held medical device company focused on mechanical thrombectomy for venous thromboembolic ...

Agreement comes on the heels of Company inking an exclusive distribution agreement with Gulf Medical for Saudi ArabiaCreates ...

Detailed price information for Icecure Medical Ltd Ord (ICCM-Q) from The Globe and Mail including charting and trades.

Company experiencing strong demand in the U.S. following FDA marketing authorization of ProSense® as the only on-label minimally invasive solution for the local treatment ...

Danaher anticipates a strong 2026 due to its diagnostic portfolio being in highly attractive areas such as molecular testing, ...

Fourth quarter revenue expected to be $15.9 million to $16.1 million, representing growth of 4% to 5%Full year revenue expected to be $56.5 ...

PRNewswire/ -- (Middletown, Delaware) a leading provider of high-value, system-critical elastomer components, announced a ...

PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...

In many organizations, Fleet operates as invisible infrastructure. It is essential to daily operations, yet often noticed ...

Markets enter a massive week marking the unofficial start of Q4 earnings season with major financial institutions including JPMorgan, Bank of America, and Goldman Sachs reporting results.